Published in J Clin Biochem Nutr on February 08, 2017
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med (1967) 16.75
Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A (1993) 13.27
A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) (1993) 4.25
Age-related macular degeneration. Lancet (2008) 3.34
Oxidative damage and age-related macular degeneration. Mol Vis (1999) 2.97
Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep (2006) 2.69
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol (2005) 2.08
Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol (1998) 1.70
Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci (1998) 1.37
Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis (2007) 1.33
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology (2001) 1.31
Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol (2009) 1.18
C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci (2008) 1.16
C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Arch Ophthalmol (2007) 1.15
Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol (2005) 1.15
Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology (2007) 1.15
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol (2007) 1.10
Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation (2000) 1.03
Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond) (2008) 0.97
Low glutathione reductase and peroxidase activity in age-related macular degeneration. Br J Ophthalmol (1994) 0.96
Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol (2005) 0.96
A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr (2014) 0.95
C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol (2003) 0.95
Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med (2005) 0.89
Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2009) 0.86
Association between oxidative stress and macromolecular damage in elderly patients with age-related macular degeneration. Aging Clin Exp Res (2011) 0.85
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration. Biochem Med (Zagreb) (2012) 0.85
A critical reevaluation of some assay methods for superoxide dismutase activity. Free Radic Biol Med (1988) 0.83
The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration. Ophthalmic Res (2011) 0.83
Tempol intake improves inflammatory status in aged mice. J Clin Biochem Nutr (2014) 0.83
Plasma redox status and premature onset of senile cataract. Rom J Intern Med (2007) 0.83
The impact of inflammation to the antioxidant defense parameters in AMD patients. Aging Clin Exp Res (2012) 0.82
Serum uric acid levels and its association with age-related macular degeneration (ARMD). Med J Malaysia (2010) 0.81
Effects of interleukin 6 on megakaryocytes and on canine platelet function. Stem Cells (1994) 0.80
Determination of uric acid concentrations in human tear fluid, aqueous humour and serum. Acta Ophthalmol (2008) 0.78